Medpace Holdings, Inc.
Congressional Trades
Whale Activity
- Increased237
- New125
- Held109
- Decreased257
- Closed56
- No prior filing34
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 2.6M | $1.60B | increased |
| AQR CAPITAL MANAGEMENT LLC | 1.4M | $863.2M | increased |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.1M | $709.2M | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.1M | $677.4M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.0M | $627.9M | decreased |
| STATE STREET CORP | 714.3K | $445.9M | increased |
| GEODE CAPITAL MANAGEMENT, LLC | 712.4K | $444.7M | increased |
| Invesco Ltd. | 501.6K | $313.1M | decreased |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 499.8K | $312.0M | increased |
| WASATCH ADVISORS LP | 465.9K | $290.8M | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 452.4K | $282.4M | increased |
| BAILLIE GIFFORD & CO | 451.8K | $282.0M | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| EWALD STEPHEN PGeneral Counsel & Corp. Secy. | Sale | −1,245 | $690.00 | $859K | Oct 29, 2026 | Form 4 ↗ |
| BURWIG SUSAN EExec. VP, Operations | Sale | −3,940 | $677.00 | $2.7M | Oct 27, 2026 | Form 4 ↗ |
| BURWIG SUSAN EExec. VP, Operations | Sale | −16.1K | $677.00 | $10.9M | Oct 26, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −22.0K | $625.47 | $13.7M | Sep 30, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −26.7K | $621.02 | $16.6M | Sep 29, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −2,410 | $620.07 | $1.5M | Sep 28, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −154 | $620.60 | $96K | Sep 25, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −27.8K | $621.33 | $17.3M | Sep 24, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −16.1K | $628.64 | $10.1M | Sep 23, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −49.0K | $628.11 | $30.8M | Sep 22, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −21.9K | $623.29 | $13.6M | Sep 21, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −10.9K | $620.40 | $6.7M | Sep 17, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −8,770 | $621.29 | $5.4M | Sep 16, 2026 | Form 4 ↗ |
| BURWIG SUSAN EExec. VP, Operations | Option exercise | +3,000 | $166.73 | $500K | Sep 15, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −16.0K | $620.84 | $9.9M | Sep 15, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −650 | $620.27 | $403K | Aug 27, 2026 | Form 4 ↗ |
| Kraft Robert O.Director | Sale | −3,858 | $617.81 | $2.4M | Aug 26, 2026 | Form 4 ↗ |
| Kraft Robert O.Director | Option exercise | +3,858 | $84.36 | $325K | Aug 26, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −4,000 | $620.03 | $2.5M | Aug 26, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director · 10% owner | Sale | −673 | $620.38 | $418K | Aug 25, 2026 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF iShares Trust | 772.1K | $408.9M | 0.33% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 724.9K | $383.9M | 0.02% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 523.7K | $277.3M | 0.15% | Jun 30, 2026 |
| T. Rowe Price Large-Cap Growth Fund T. Rowe Price Equity Funds, Inc. | 376.4K | $199.3M | 0.97% | Jun 30, 2026 |
| Invesco S&P MidCap Quality ETF Invesco Exchange-Traded Fund Trust | 295.8K | $170.7M | 3.13% | Jul 31, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 302.1K | $160.0M | 0.34% | Jun 30, 2026 |
| VANGUARD EXPLORER FUND | 269.6K | $155.6M | 0.70% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 258.8K | $137.0M | 0.14% | Jun 30, 2026 |
| State Street SPDR S&P MidCap 400SM ETF Trust SPDR S&P MIDCAP 400 ETF TRUST | 173.6K | $91.9M | 0.33% | Jun 30, 2026 |
| FULLERTHALER BEHAVIORAL SMALL CAP EQUITY Capitol Series Trust | 173.0K | $91.6M | 0.72% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list MEDP's shares (CUSIP 58506Q109), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
- T. Rowe Price Associates, Inc.SCHEDULE 13G/A · passive (13G) · 1.1M shares4.1%
Nov 16, 2026 · ↗ - AQR Capital Management Holdings, LLCSCHEDULE 13G · passive (13G) · 1.4M shares5.0%
Nov 13, 2026 · ↗ - AQR Capital Management, LLCSCHEDULE 13G · passive (13G) · 1.4M shares5.0%
Nov 13, 2026 · ↗ - Medpace Investors, LLCSCHEDULE 13D/A · activist (13D) · 4.7M shares16.8%
Sep 28, 2026 · ↗ - August J. TroendleSCHEDULE 13D/A · activist (13D) · 5.4M shares19.1%
Sep 28, 2026 · ↗ - T. Rowe Price Associates, Inc.SCHEDULE 13G · passive (13G) · 2.1M shares7.2%
Aug 14, 2026 · ↗
Corporate Lobbying
No lobbying filings found naming Medpace Holdings, Inc. as the client.
Government Contracts
No federal contract awards found for Medpace Holdings, Inc..
U.S. Patents
No USPTO patent applications found for Medpace Holdings, Inc..
Annual Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.53B | $2.11B | $1.89B | $1.46B | $1.14B |
| Operating income | $534.9M | $446.9M | $336.8M | $278.7M | $198.6M |
| Net income | $451.1M | $404.4M | $282.8M | $245.4M | $181.8M |
| Diluted EPS | $15.28 | $12.63 | $8.88 | $7.28 | $4.81 |
| Operating cash flow | $713.2M | $608.8M | $433.4M | $388.1M | $263.3M |
| Cash and equivalents | $497.0M | $669.4M | $245.4M | $28.3M | $461.3M |
| Total assets | $1.98B | $2.10B | $1.66B | $1.35B | $1.66B |
| Total liabilities | $1.52B | $1.28B | $1.10B | $966.1M | $707.0M |
| Shareholders' equity | $459.1M | $825.5M | $559.0M | $386.4M | $952.9M |
As Medpace Holdings, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 10, 2026 ↗
Stock Splits
No stock splits in MEDP's price history.






